MedTrace Logo

Low-Intensity Focused Ultrasound (LIFU) Neuromodulation

NCT05997030 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-11-24

No results posted yet for this study

Summary

This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with mild cognitive impairment ( MCI) due to Alzheimer's disease.

Conditions

  • Alzheimer Disease

Interventions

DEVICE

low intensity focused ultrasound (LIFU)

Subjects will undergo undergo a single LIFU of the target brain region

Sponsors & Collaborators

  • Ali Rezai

    lead OTHER

Principal Investigators

  • Ali Rezai, MD · WVU Rockefeller Neuroscience Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-12
Primary Completion
2026-09-30
Completion
2026-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05997030 on ClinicalTrials.gov